Tang et al. [60] (Table 1) assessed EGFR mutation heterogeneity in primary tumours and corresponding lymph node metastases from 9 EGFR mutation-positive patients, by taking multiple samples from non-contiguous sites of both primary tumours and metastases. Here, EGFR is linked to neoplasm.